PRECISE-RA
Research type
Research Study
Full title
PRECISion medicinE across the disease continuum to prevent and treat Rheumatoid Arthritis
IRAS ID
281253
Contact name
Maya H Buch
Contact email
Sponsor organisation
The University of Manchester
Clinicaltrials.gov Identifier
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
The researchers would like to know more about early arthritis with the aim of identifying it at the earliest time point. This is important as there are still many things that are not known about this, and finding out more could improve how patients are treated in future. Therefore, they have proposed this study which will involve recruitment of patients referred to the Rheumatology out-patient departments at and/or age and sex- matched controls as needed. Participant with RA will be recruited on to the main study, whereby the researchers will collect clinical information about them and the participants will complete questionnaires. The participants with RA could also be approached to take part in one of the following sub-studies; biosample, in which blood and urine samples would be collected; synovial, whereby synovial fluid and biopsy studies will be collected. The research is to be funded by the Manchester Biomedical Research Centre. The Control Group Study will also aim to collect this information, for comparison. The study will recruit in specialist NHS centres; recruitment will start in Manchester University Hospitals NHS Foundation Trust and other centres may be involved in future.
REC name
South East Scotland REC 01
REC reference
20/SS/0090
Date of REC Opinion
30 Dec 2020
REC opinion
Further Information Favourable Opinion